afatinib,sotorasib,pembrolizumab,panitumumab,binimetinib,cetuximab,adagrasib,encorafenib
takeda,boehringer ingelheim,eli lilly,pfizer,array biopharma,merck,mirati,amgen
['315o', 'cetuximab', 'adagrasib', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'sotorasib', 'krystal-1', 'panitumumab', 'lba24']
couple of interesting presentations on krasg12c mutated #crc at #esmo2022: 12/09/2022, 10:15 lba24 (krystal-1: efficacy &amp; safety of #adagrasib with/without #cetuximab) 315o (safety and efficacy of #sotorasib plus #panitumumab) #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB